bpc-157 clinical trials human safety If worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of The Hidden Risks of BPC‑157:

GHK administered intraperitoneally at doses of 2.6, 26, and 260 g/ml/day reduced inflammatory cell infiltration, levels of TNF- and IL-6, as well as abolished bleomycin-induced elevation of TGF-beta in bleomycin-induced lung fibrosis in mice

Hormonal and blood-sugar disruption, including elevated cortisol and prolactin, reduced insulin sensitivity, and hypoglycemia risk tied to IGF-1 receptor activity

Fix any issues you discover

Think of it this way: peptides work from the inside out, signaling your cells to repair tissue and reduce inflammation

The hip-spine connection: how to differentiate hip conditions from spine pathology